Optimizing combination chemotherapy for Kaposi's sarcoma

Cancer J Sci Am. 1997 Sep-Oct;3(5):268-70.

Authors

R Yarchoan¹, R Little

Affiliation

¹ HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1906, USA.

PMID: 9327148

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
HIV Infections / complications
Humans
Lung Neoplasms / drug therapy*
Sarcoma, Kaposi / drug therapy*

Substances

Granulocyte-Macrophage Colony-Stimulating Factor